News

Interdisciplinary GU Cancer Forum 2025, non muscle invasive bladder cancer (NMIBC), Novel Agents in NMIBC, EV-104 trial, SunRISe bladder trials, TAR-200, BOND-003 trial, CREST Trial, sasanlimab, ...